{"component": "definition", "props": {"groups": [{"samples": [{"hash": "kYgdwSk3fcl", "uri": "/contracts/kYgdwSk3fcl#rd-program", "label": "License Agreement (Ribozyme Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "juZh0SFCFET", "uri": "/contracts/juZh0SFCFET#rd-program", "label": "License Agreement (Ribozyme Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "iipm6MFp7EC", "uri": "/contracts/iipm6MFp7EC#rd-program", "label": "License Agreement (Sheffield Pharmaceuticals Inc)", "score": 18.0, "published": true}], "snippet": "means any research and development program commenced by Newco pursuant to the Project.", "snippet_links": [{"key": "research-and-development-program", "type": "definition", "offset": [10, 42]}, {"key": "by-newco", "type": "clause", "offset": [53, 61]}, {"key": "the-project", "type": "definition", "offset": [74, 85]}], "size": 13, "hash": "8e5f86d09bc1517e1924ac2863eab200", "id": 1}, {"samples": [{"hash": "25tl54bJL63", "uri": "/contracts/25tl54bJL63#rd-program", "label": "Master Collaboration and License Agreement", "score": 32.8356335025, "published": true}, {"hash": "5RZPiYInoI7", "uri": "/contracts/5RZPiYInoI7#rd-program", "label": "Master Collaboration and License Agreement (Moderna, Inc.)", "score": 29.8542094456, "published": true}, {"hash": "8SXfpMngZh8", "uri": "/contracts/8SXfpMngZh8#rd-program", "label": "Master Collaboration and License Agreement (Moderna, Inc.)", "score": 29.8295687885, "published": true}], "snippet": "means each collaborative program of Development activities established in accordance with Sections 2.3(a) or 2.7, as applicable, and conducted by or on behalf of the Parties during the R&D Term in accordance with the terms and conditions of this Agreement, and that is not a Discontinued R&D Program.", "snippet_links": [{"key": "collaborative-program", "type": "clause", "offset": [11, 32]}, {"key": "development-activities", "type": "definition", "offset": [36, 58]}, {"key": "in-accordance-with", "type": "definition", "offset": [71, 89]}, {"key": "of-the-parties", "type": "clause", "offset": [159, 173]}, {"key": "rd-term", "type": "definition", "offset": [185, 193]}, {"key": "terms-and-conditions-of-this-agreement", "type": "clause", "offset": [217, 255]}], "size": 6, "hash": "bf2de9d4138d304b92fe72ae3bb5990c", "id": 2}, {"samples": [{"hash": "hI0OfYGhypz", "uri": "/contracts/hI0OfYGhypz#rd-program", "label": "Collaborative Research Agreement (Diversa Corp)", "score": 18.0, "published": true}, {"hash": "diqh7Gk4DKK", "uri": "/contracts/diqh7Gk4DKK#rd-program", "label": "Collaborative Research Agreement (Diversa Corp)", "score": 18.0, "published": true}, {"hash": "awCJeCKWML7", "uri": "/contracts/awCJeCKWML7#rd-program", "label": "Collaborative Research Agreement (Diversa Corp)", "score": 18.0, "published": true}], "snippet": "means the research and development program to be conducted ----------- during the Research Term by DIVERSA and DOW pursuant to Section 2, as more fully described [*****].", "snippet_links": [{"key": "research-and-development-program", "type": "definition", "offset": [10, 42]}, {"key": "during-the-research-term", "type": "clause", "offset": [71, 95]}, {"key": "pursuant-to-section-2", "type": "clause", "offset": [115, 136]}], "size": 5, "hash": "926dbec5688826db53033edb300f3333", "id": 3}, {"samples": [{"hash": "k3vplEZFM6J", "uri": "/contracts/k3vplEZFM6J#rd-program", "label": "Non Exclusive Patent License (Cutera Inc)", "score": 21.0, "published": true}, {"hash": "h0P0Emmryzz", "uri": "/contracts/h0P0Emmryzz#rd-program", "label": "Non Exclusive Patent License (Cynosure Inc)", "score": 21.0, "published": true}, {"hash": "1Y11yxr7vJF", "uri": "https://ir.cutera.com/static-files/54259f39-52ff-4b9f-8935-cfe077c00aa1", "label": "ir.cutera.com", "score": 10.1704312115, "published": false}], "snippet": "means the program of R&D Activities carried out by the parties pursuant to the R&D Plan.", "snippet_links": [{"key": "the-program", "type": "clause", "offset": [6, 17]}, {"key": "activities-carried", "type": "clause", "offset": [25, 43]}, {"key": "by-the-parties", "type": "clause", "offset": [48, 62]}, {"key": "pursuant-to-the", "type": "clause", "offset": [63, 78]}, {"key": "rd-plan", "type": "clause", "offset": [79, 87]}], "size": 4, "hash": "8d056d3549daf52ac121250b175891b7", "id": 4}, {"samples": [{"hash": "gCnV8JQj68N", "uri": "/contracts/gCnV8JQj68N#rd-program", "label": "License Agreement (Zogenix, Inc.)", "score": 20.6707734428, "published": true}, {"hash": "gI4eCsfehiO", "uri": "/contracts/gI4eCsfehiO#rd-program", "label": "License Agreement (Zogenix Inc)", "score": 20.0, "published": true}, {"hash": "aagGZYq9MAU", "uri": "/contracts/aagGZYq9MAU#rd-program", "label": "License Agreement (Zogenix Inc)", "score": 20.0, "published": true}], "snippet": "means the research and development program related to the Product set out in the Services Agreement.", "snippet_links": [{"key": "research-and-development-program", "type": "definition", "offset": [10, 42]}, {"key": "related-to", "type": "clause", "offset": [43, 53]}, {"key": "set-out", "type": "definition", "offset": [66, 73]}, {"key": "the-services-agreement", "type": "clause", "offset": [77, 99]}], "size": 3, "hash": "833ee4c330ff345c494cc9d27536f078", "id": 5}, {"samples": [{"hash": "B5xSDqaeIH", "uri": "/contracts/B5xSDqaeIH#rd-program", "label": "Drug Discovery, Development, and License Agreement (Intrabiotics Pharmaceuticals Inc /De)", "score": 21.0, "published": true}, {"hash": "40ibNVuxO3Q", "uri": "/contracts/40ibNVuxO3Q#rd-program", "label": "Drug Discovery, Development, and License Agreement (Intrabiotics Pharmaceuticals Inc /De)", "score": 21.0, "published": true}, {"hash": "cipV2prvwpm", "uri": "/contracts/cipV2prvwpm#rd-program", "label": "Drug Discovery, Development, and License Agreement (Diversa Corp)", "score": 18.0, "published": true}], "snippet": "means the research and development program to be conducted by Diversa and IBP pursuant to Section 2, as more fully described in the Work Plan. The R&D Program with respect to a given compound in a Compound Set shall end upon the earliest of (i) the date that an investigational new drug application (or equivalent application outside of the United States) is filed for a Product containing such compound or (ii) the date that any License with respect to such compound terminates.", "snippet_links": [{"key": "research-and-development-program", "type": "definition", "offset": [10, 42]}, {"key": "pursuant-to-section-2", "type": "clause", "offset": [78, 99]}, {"key": "the-work-plan", "type": "clause", "offset": [128, 141]}, {"key": "with-respect-to", "type": "clause", "offset": [159, 174]}, {"key": "investigational-new-drug-application", "type": "clause", "offset": [262, 298]}, {"key": "or-equivalent", "type": "definition", "offset": [300, 313]}, {"key": "outside-of-the-united-states", "type": "clause", "offset": [326, 354]}], "size": 3, "hash": "782a885164063115c0cc173d36bd9203", "id": 6}, {"samples": [{"hash": "k6ioPFDpuhr", "uri": "/contracts/k6ioPFDpuhr#rd-program", "label": "Collaboration, License and Option Agreement (Curis Inc)", "score": 32.2032854209, "published": true}, {"hash": "a2jP81icHKG", "uri": "/contracts/a2jP81icHKG#rd-program", "label": "Collaboration, License and Option Agreement", "score": 31.340862423, "published": true}, {"hash": "dO0MNV8xez7", "uri": "/contracts/dO0MNV8xez7#rd-program", "label": "Collaboration, License and Option Agreement (Curis Inc)", "score": 26.1471594798, "published": true}], "snippet": "means, with respect to each Initial PTP, a program of discovery, research and preclinical development aimed at generating a Development Candidate and back-up Program Compounds directed to the applicable Program Target Profile.", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "research-and-preclinical-development", "type": "clause", "offset": [65, 101]}, {"key": "aimed-at", "type": "definition", "offset": [102, 110]}, {"key": "development-candidate", "type": "definition", "offset": [124, 145]}, {"key": "program-compounds", "type": "definition", "offset": [158, 175]}, {"key": "directed-to", "type": "definition", "offset": [176, 187]}, {"key": "program-target", "type": "definition", "offset": [203, 217]}], "size": 3, "hash": "787fc691908a0e4a2d3a088160c5b266", "id": 7}, {"samples": [{"hash": "kXnyLi1vinF", "uri": "/contracts/kXnyLi1vinF#rd-program", "label": "Collaborative Research and License Agreement (Maxygen Inc)", "score": 18.0, "published": true}, {"hash": "j7W6y3JqwRS", "uri": "/contracts/j7W6y3JqwRS#rd-program", "label": "Collaborative Research and License Agreement (Maxygen Inc)", "score": 18.0, "published": true}, {"hash": "hedo8OB5k7E", "uri": "/contracts/hedo8OB5k7E#rd-program", "label": "Collaborative Research and License Agreement (Maxygen Inc)", "score": 18.0, "published": true}], "snippet": "means the research and development program to be conducted by MAXYGEN and PIONEER pursuant to Section 2 and as described in the Work Plan.", "snippet_links": [{"key": "research-and-development-program", "type": "definition", "offset": [10, 42]}, {"key": "pursuant-to-section-2", "type": "clause", "offset": [82, 103]}, {"key": "the-work-plan", "type": "clause", "offset": [124, 137]}], "size": 3, "hash": "5c919816e2203025b5dfad1a4172c5fa", "id": 8}, {"samples": [{"hash": "fRXBkO4eLhj", "uri": "/contracts/fRXBkO4eLhj#rd-program", "label": "Development and License Agreement (Acologix, Inc.)", "score": 21.0, "published": true}, {"hash": "DcWcQE5IFm", "uri": "/contracts/DcWcQE5IFm#rd-program", "label": "Development and License Agreement (Acologix, Inc.)", "score": 21.0, "published": true}], "snippet": "has the meaning set forth in Section 3.1.", "snippet_links": [{"key": "section-31", "type": "clause", "offset": [29, 40]}], "size": 3, "hash": "3d19223e249d2e344053d0014b14d616", "id": 9}, {"samples": [{"hash": "79rcHfhA7cy", "uri": "/contracts/79rcHfhA7cy#rd-program", "label": "Joint Research and Development and License Agreement (NaturalNano , Inc.)", "score": 21.0, "published": true}, {"hash": "3JPvfC7dXAO", "uri": "/contracts/3JPvfC7dXAO#rd-program", "label": "Joint Research and Development and License Agreement (NaturalNano , Inc.)", "score": 21.0, "published": true}], "snippet": "means a joint research and development program to develop one or more Products pursuant to a Program Plan.", "snippet_links": [{"key": "research-and-development-program", "type": "definition", "offset": [14, 46]}, {"key": "to-develop", "type": "definition", "offset": [47, 57]}, {"key": "pursuant-to-a", "type": "definition", "offset": [79, 92]}, {"key": "program-plan", "type": "clause", "offset": [93, 105]}], "size": 3, "hash": "5db8310cbf4a52661abbc3b4a3484a4f", "id": 10}], "next_curs": "ClcSUWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjMLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiITcmQtcHJvZ3JhbSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means any research and development program commenced by Newco pursuant to the Project.", "title": "R&D Program", "size": 93, "id": "rd-program", "examples": ["For clarity, unless otherwise mutually agreed in writing by the Parties, in no event shall Moderna be entitled to receive payment for (and Moderna shall be solely responsible for) any FTEs or other R&D Program Costs in a given Calendar Quarter in connection with the performance of activities that are not included in the applicable R&D Plan or that are not specifically included in the budget set forth therein.", "Moderna will have the right to terminate this Agreement in full in the event of a material breach by Merck of this Agreement; provided, that to the extent that any such material breach is limited to a particular R&D Program, Product Candidate, Elected Candidate, Product or country, Moderna will have the right to terminate this Agreement only with respect to such R&D Program, Product Candidate, Elected Candidate, Product or country to which such material breach primarily relates.", "Any R&D Program that is being replaced by a new R&D Program will be a Discontinued Program hereunder.", "If an R&D Program Proposal submitted by Merck satisfies the requirements of this Section 2.3(a), Section 2.3(b) and Section 2.3(c), the proposed R&D Program will become an R&D Program hereunder.", "Furthermore, during the R&D Term, Merck at its sole discretion may add or remove any Merck Exclusive Target as an R&D Target of an established R&D Program by providing written notice to Moderna.", "Moderna shall notify Merck in writing immediately if any such debarment occurs or comes to its attention, and shall, with respect to any person or entity so debarred promptly remove such person or entity from performing any R&D Program activities and other activities hereunder, function or capacity related thereto.", "Any animals which are used in the course of an R&D Program or other activities hereunder, or products derived from those animals, such as eggs or milk, will not be used for food purposes, nor will these animals be used for commercial breeding purposes.", "After the execution of this Agreement, Moderna shall notify Merck in writing immediately if any Violation occurs or comes to its attention, and shall, with respect to any person or entity in Violation, promptly remove such person or entity from performing any R&D Program activities or and other activities hereunder, function or capacity related thereto.", "Each Party will perform its respective activities for a given R&D Program as set forth in the R&D Plan for such R&D Program until the earlier to occur of [***].", "For each R&D Program, Moderna shall design [***] Collaboration mRNA Constructs [***], and such Collaboration mRNA Constructs will be Manufactured and supplied by or on behalf of Moderna in accordance with Section 4.1 for use in the applicable R&D Program."], "related": [["development-program", "Development Program", "Development Program"], ["research-program", "Research Program", "Research Program"], ["research-plan", "Research Plan", "Research Plan"], ["research-program-term", "Research Program Term", "Research Program Term"], ["licensed-program", "Licensed Program", "Licensed Program"]], "related_snippets": [], "updated": "2025-07-06T21:55:40+00:00"}, "json": true, "cursor": ""}}